J. Virol., 11 1996, 7678-7685, Vol 70, No. 11
Copyright © 1996, American Society for Microbiology

A recombinant vaccinia virus encoding inducible nitric oxide synthase is attenuated in vivo

MS Rolph, WB Cowden, CJ Medveczky and IA Ramshaw
Division of Immunology and Cell Biology, John Curtin School of Medical Research, Australian National University, Canberra, Australia. michael.rolph@anu.edu.au.

To investigate the role of nitric oxide during vaccinia virus (VV) infection of mice, a recombinant VV encoding the inducible nitric oxide synthase (iNOS) gene (VV-HA-iNOS) was constructed. Following infection of immunocompromised or immunocompetent mice, the virus was highly attenuated compared with a control recombinant VV. Athymic and sublethally irradiated mice survived infection with 10(7) PFU of VV-HA- iNOS, a dose that resulted in uniform mortality in mice infected with the control recombinant VV. Attenuated virus growth was evident as early as 24 h following infection, suggesting that NO had direct antiviral activity. We have previously shown that treatment of mice with the inhibitor of NO production N(G)-methyl-L-arginine did not influence the course of VV infection in mice. The present study has indicated that NO can potentially exert an antiviral effect during murine VV infection. We propose that during VV infection, nitric oxide production contributes to the control of virus growth, but that in its absence, other antiviral mechanisms are sufficient to mediate fully effective virus clearance.

This article has been cited by other articles:

• Cameron, C. M., Barrett, J. W., Liu, L., Lucas, A. R., McFadden, G. (2005). Myxoma Virus M141R Expresses a Viral CD200 (vOX-2) That Is Responsible for Down-Regulation of Macrophage and T-Cell Activation In Vivo. J. Virol. 79: 6052-6067 [Abstract] [Full Text]  
• Reading, P. C., Smith, G. L. (2003). Vaccinia Virus Interleukin-18-Binding Protein Promotes Virulence by Reducing Gamma Interferon Production and Natural Killer and T-Cell Activity. J. Virol. 77: 9960-9968 [Abstract] [Full Text]  
• Reading, P. C., Smith, G. L. (2003). A kinetic analysis of immune mediators in the lungs of mice infected with vaccinia virus and comparison with intradermal infection. J. Gen. Virol. 84: 1973-1983 [Abstract] [Full Text]  
• van den Broek, M., Bachmann, M. F., Kohler, G., Barner, M., Escher, R., Zinkernagel, R., Kopf, M. (2000). IL-4 and IL-10 Antagonize IL-12-Mediated Protection Against Acute Vaccinia Virus Infection with a Limited Role of IFN-{gamma} and Nitric Oxide Synthetase 2. J. Immunol. 164: 371-378 [Abstract] [Full Text]  
• Karupiah, G., Chen, J.-H., Nathan, C. F., Mahalingam, S., MacMicking, J. D. (1998). Identification of Nitric Oxide Synthase 2 as an Innate Resistance Locus against Ectromelia Virus Infection. J. Virol. 72: 7703-7706 [Abstract] [Full Text]  
• Lopez-Guerrero, J. A., Carrasco, L. (1998). Effect of Nitric Oxide on Poliovirus Infection of Two Human Cell Lines. J. Virol. 72: 2538-2540 [Abstract] [Full Text]